Lazarus CDS leverages Artificial Intelligence to improve early cancer detection by turning a primary care doctor into a specialist for 5 minutes. For diseases like cervical cancer, this is as simple as a simple prompt that alerts physicians of high-risk patients, enabling them to make better clinical decisions. In skin cancer, we turn any mobile device into an AI-powered dermascope, automatically classifying risk based on a whole host of factors. Best of all, it's fully explainable. No black boxes, just real results.

Lazarus uses patient health data and AI to detect cancer early. The company has clinical decision support systems for skin and cervical cancer, which help improve the diagnostic accuracy of physicians.

CuraRad-ICH is a software workflow prioritization tool designed to reduce radiologist turnaround time for suspected intracranial hemorrhage (ICH) cases in non-contrast head CT scans. The software uses a deep learning neural network to detect ICH in seconds, prioritizing suspected ICH cases on the worklist and flagging for urgent attention. CuraRad-ICH received 510(k) clearance from the U.S. Food & Drug Administration on April 13, 2020.